Follow
Ramon Colomer
Ramon Colomer
Universidad Autónoma de Madrid, Hospital La Princesa, Madrid, Spain
Verified email at seom.org
Title
Cited by
Cited by
Year
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
M Aapro, PA Abrahamsson, JJ Body, RE Coleman, R Colomer, L Costa, ...
Annals of oncology 19 (3), 420-432, 2008
5582008
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells
JA Menendez, L Vellon, I Mehmi, BP Oza, S Ropero, R Colomer, R Lupu
Proceedings of the National Academy of Sciences 101 (29), 10715-10720, 2004
3952004
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
R Porta, JM Sanchez-Torres, L Paz-Ares, B Massuti, N Reguart, C Mayo, ...
European Respiratory Journal 37 (3), 624-631, 2011
3822011
International conference on the healthy effect of virgin olive oil
Jaen
European journal of clinical investigation 35 (7), 421-424, 2005
3452005
Direct Interaction of a Ligand for the erbB2 Oncogene Product with the EGF Receptor and p185erbB2
R Lupu, R Colomer, G Zugmaier, J Sarup, M Shepard, D Slamon, ...
Science 249 (4976), 1552-1555, 1990
3371990
Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab …
JA Menendez, L Vellon, R Colomer, R Lupu
Annals of oncology 16 (3), 359-371, 2005
3202005
N-3 fatty acids, cancer and cachexia: a systematic review of the literature
R Colomer, JM Moreno-Nogueira, PP García-Luna, P García-Peris, ...
British Journal of Nutrition 97 (5), 823-831, 2007
3172007
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
SRD Johnston, N Harbeck, R Hegg, M Toi, M Martin, ZM Shao, QY Zhang, ...
Journal Clinical Oncology 38 (34), 2020
3082020
Neratinib plus paclitaxel vs trastuzumab plus paclitaxel in previously untreated metastatic ERBB2-positive breast cancer: the NEfERT-T randomized clinical trial
A Awada, R Colomer, K Inoue, I Bondarenko, RA Badwe, G Demetriou, ...
JAMA oncology 2 (12), 1557-1564, 2016
2802016
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
A Vazquez‐Martin, R Colomer, J Brunet, R Lupu, JA Menendez
Cell proliferation 41 (1), 59-85, 2008
2192008
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
JA Menendez, A Vazquez-Martin, R Colomer, J Brunet, ...
BMC cancer 7 (1), 1-19, 2007
2152007
Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer
R Colomer, S Montero, A Lluch, B Ojeda, A Barnadas, A Casado, ...
Clinical Cancer Research 6 (6), 2356-2362, 2000
2152000
CCR5 expression influences the progression of human breast cancer in a p53-dependent manner
S Mañes, E Mira, R Colomer, S Montero, LM Real, C Gómez-Moutón, ...
The Journal of experimental medicine 198 (9), 1381-1389, 2003
2072003
Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis.
H Gómez, M Hidalgo, L Casanova, R Colomer, DL Pen, J Otero, ...
Journal of clinical oncology 16 (6), 2065-2069, 1998
1861998
Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells
JA Menendez, M del Mar Barbacid, S Montero, E Sevilla, E Escrich, ...
European journal of cancer 37 (3), 402-413, 2001
1832001
Mediterranean diet, olive oil and cancer
R Colomer, JA Menéndez
Clinical and Translational Oncology 8 (1), 15-21, 2006
1822006
Overexpression of c‐erbB‐2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy
E Felip, JM Del Campo, D Rubio, MT Vidal, R Colomer, B Bermejo
Cancer 75 (8), 2147-2152, 1995
1721995
Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients
J Rogado, JM Sánchez-Torres, N Romero-Laorden, AI Ballesteros, ...
European Journal of Cancer 109, 21-27, 2019
1682019
Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors
JI Mayordomo, F Rivera, MT Diaz-Puente, P Lianes, R Colomer, ...
JNCI: Journal of the National Cancer Institute 87 (11), 803-808, 1995
1651995
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53 …
JA Menendez, I Mehmi, E Atlas, R Colomer, R Lupu
International journal of oncology 24 (3), 591-608, 2004
1592004
The system can't perform the operation now. Try again later.
Articles 1–20